Immunogenicity and safety of recombinant influenza vaccine versus standard inactivated influenza vaccine in children aged 3 to 8 years: results from a phase III randomised study

Vaccine 2026 Open access

Read full text

Authors: Pedro M. Folegatti, Stéphanie Pépin, Cynthia Tabar, Katherine Fries, Oxana Talanova, Stephanie See, Kathleen Kaas-Leach, Iris De Bruijn

DOI: 10.1016/j.vaccine.2026.128582

Cited by: 1

References: 20

Fields of Study & Subjects

Influenza Virus Research Studies Pharmacovigilance and Adverse Drug Reactions Immune responses and vaccinations

References 20